Avadel Pharmaceuticals to Share Innovations at Healthcare Conference

Author: Logan Wright Updated: 04-01-2025 08:20 AM

Avadel Pharmaceuticals Engages at Needham Healthcare Conference

Dublin – Avadel Pharmaceuticals plc (Nasdaq: AVDL), a pioneering biopharmaceutical company dedicated to innovative drug development, is set to make a significant appearance at the 24th Annual Needham Healthcare Conference. Management from Avadel will engage in a thoughtful fireside chat scheduled for April 8 at 1:30 p.m. ET, where they will discuss the company’s strategic direction and pipeline of transformative medicines.

Webcast and Further Engagement

Participants interested in the discussion can access a live webcast of the flameside chat. An archived version will be available on their Investor Relations website for 90 days following the event, allowing for broader accessibility to those unable to attend live.

About Avadel Pharmaceuticals

Avadel Pharmaceuticals is committed to enhancing the lives of patients through innovative treatments. Known for its flagship product, LUMRYZ™, Avadel has made a groundbreaking impact by being the first and only once-at-bedtime oxybate approved by the U.S. Food & Drug Administration (FDA) for treating cataplexy or excessive daytime sleepiness in individuals with narcolepsy aged 7 and older. This advancement illustrates Avadel’s commitment to addressing critical needs in the healthcare sector.

Transformative Solutions in Medicine

The company aims to reshape the treatment landscape by leveraging its expertise in drug formulation and production. Their approach involves not only developing advanced therapeutic options but also focusing on user experience and accessibility, ensuring that patients receive the best possible care. By advocating for innovative solutions, Avadel strives to alleviate challenges faced by patients across various conditions.

Investor and Media Contacts

Avadel Pharmaceuticals values open communication with its stakeholders. For inquiries regarding investments or media coverage, here are the contact details:

Investor Contact

Austin Murtagh
Precision AQ
Email: Austin.Murtagh@precisionAQ.com
Phone: (212) 698-8696

Media Contact

Lesley Stanley
Real Chemistry
Email: lestanley@realchemistry.com
Phone: (609) 273-3162

Frequently Asked Questions

What is the purpose of the fireside chat at the healthcare conference?

The fireside chat aims to provide insights into Avadel's strategic direction and innovations in drug development.

How can I access the presentation from the conference?

You can access the live webcast of the presentation on Avadel's Investor Relations page, with an archived version available for 90 days afterward.

What is LUMRYZ™?

LUMRYZ™ is Avadel's approved product designed for once-at-bedtime oxybate treatment, specifically for patients with narcolepsy.

Who can I contact for investor relations?

Austin Murtagh from Precision AQ is the contact for any investor-related inquiries.

How does Avadel Pharmaceuticals innovate in the biopharmaceutical field?

Avadel focuses on developing innovative treatment options that address the significant challenges faced by patients using current medication therapies.

About The Author

Dedicated Author and financial expert Logan Wright here, 29 years old. After earning an economics degree, I spent a number of years working in different financial industries. My great passion is enabling everyone, from any background or experience level, to understand and be literate in financial matters.

My books and writings are centered on simplifying difficult financial ideas into doable, understandable guidance. Whether it's retirement planning, investing, or budgeting, I want to arm readers with the information they need to make wise financial choices and realize their financial objectives.

Apart from writing, I also frequently post to financial blogs and organize webinars and workshops targeted at enlightening participants about personal finance. Always, my strategy is to offer concise, doable advice that can truly improve people's lives.

Away from work, I like to read, travel, and sample new foods. My goal is to infuse everything I do with the balance that I think is essential to both financial and personal well-being. By my profession, I want to encourage and enable people to confidently and clearly take charge of their financial futures.

Contact Logan Wright privately here. Or send an email with ATTN: Logan Wright as the subject to contact@investorshangout.com.

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.